Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HASS-2: Hypertension Guideline Implementation
NCT03921086Completed
- Sponsor
- University of Cape Town
- Start
- Jan 2019
- Primary completion
- Mar 2019
- Countries
- 1
01
Overview
Open-label, single-arm trial in hypertension (HTN), sponsored by University of Cape Town. Primary endpoints: Physician compliance with prescription of in-hospital drugs according to hypertension algorithm at 5 days and Physician compliance with prescription of discharge drugs according to hypertension algorithm at 5 days. Started Jan 2019; status: completed.
02
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03921086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03921086.